bluebird bio, Inc. Equity-NMS: BLUE

$4.33 -0.14 (December 6, 2023)

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$4.47
Open :$4.55
Today's high :$4.55
Today's low :$4.31
52W low :$2.52
52W high :$8.52
1Y :-43.37%
5Y :-95.97%
EPS(TTM): :-0.8973
Shares O/S :109.34 M
Market cap :473.43 M

Compare with Other Stocks

Frequently Asked Questions

What is the share price of bluebird bio, Inc. today?

bluebird bio, Inc. (BLUE) share price as of December 6, 2023, is $4.33. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of bluebird bio, Inc.?

Yes, Indian Investors can invest in the bluebird bio, Inc. (BLUE) Share by opening an international trading account with Angel One.

How can I purchase bluebird bio, Inc. shares in India?

Purchasing bluebird bio, Inc. (BLUE) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying bluebird bio, Inc. (BLUE) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of bluebird bio, Inc.?

Yes, you can purchase fractional shares of bluebird bio, Inc. (BLUE) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of bluebird bio, Inc.?

The market capitalization of bluebird bio, Inc. on December 6, 2023, is $473.43 M.

In which sector bluebird bio, Inc. belongs?

bluebird bio, Inc. operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in bluebird bio, Inc. stocks?

In order to invest in bluebird bio, Inc. (BLUE) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About bluebird bio, Inc.

bluebird bio, Inc. is a biotechnology company. The Company is focused on researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its lentiviral vector (LVV) gene addition platform. Its lead gene therapy programs for sickle cell disease, B-thalassemia, and cerebral adrenoleukodystrophy and is advancing research to apply new technologies to these and other diseases. It has two gene therapies: ZYNTEGLO (betibeglogene autotemcel) and SKYSONA (elivaldogene autotemcel). ZYNTEGLO is the first gene therapy for people with B-thalassemia who require regular red blood cell transfusions. SKYSONA (elivaldogene autotemcel), also known as eli-cel, is used to slow the progression of eurologic dysfunction in boys 4-17 years of age with early, active cerebral adrenoleukodystrophy (CALD). It is also developing (lovotibeglogene autotemcel), also known as lovo-cel, as a one-time treatment for patients with sickle cell disease (SCD).